Abercrombie & Fitch (ANF) 10-Q 5 Dec 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Oct. 29, 2016	Dec. 01, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	ABERCROMBIE & FITCH CO /DE/
Entity Central Index Key	1,018,840
Current Fiscal Year End Date	--01-28
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Oct. 29, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		67,674,988

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Net sales	$ 821,734	$ 878,572	$ 2,290,377	$ 2,405,750
Cost of sales, exclusive of depreciation and amortization	310,995	318,785	876,810	924,552
Gross profit	510,739	559,787	1,413,567	1,481,198
Stores and distribution expense	386,609	392,942	1,138,644	1,173,773
Marketing, general and administrative expense	105,307	117,698	331,473	345,077
Restructuring benefit	0	0	0	(1,598)
Asset impairment	0	12,076	6,356	18,209
Other operating income, net	(822)	(3,919)	(16,835)	(7,018)
Operating income (loss)	19,645	40,990	(46,071)	(47,245)
Interest expense, net	4,609	4,586	13,856	13,792
Income (loss) before taxes	15,036	36,404	(59,927)	(61,037)
Income tax expense (benefit)	6,762	(5,881)	(17,540)	(40,688)
Net income (loss)	8,274	42,285	(42,387)	(20,349)
Less: Net income attributable to noncontrolling interests	393	394	2,448	1,816
Net income (loss) attributable to A&F	$ 7,881	$ 41,891	$ (44,835)	$ (22,165)
Net income (loss) per share attributable to A&F
Basic	$ 0.12	$ 0.61	$ (0.66)	$ (0.32)
Diluted	$ 0.12	$ 0.60	$ (0.66)	$ (0.32)
Weighted-average shares outstanding
Basic	67,975	68,866	67,848	69,363
Diluted	68,277	69,265	67,848	69,363
Dividends declared per share	$ 0.20	$ 0.20	$ 0.60	$ 0.60
Other comprehensive (loss) income
Foreign currency translation, net of tax	$ (12,194)	$ (1,491)	$ 870	$ (11,362)
Derivative financial instruments, net of tax	3,937	(2,952)	557	(11,288)
Other comprehensive (loss) income	(8,257)	(4,443)	1,427	(22,650)
Comprehensive income (loss)	17	37,842	(40,960)	(42,999)
Less: Comprehensive income attributable to noncontrolling interests	393	394	2,448	1,816
Comprehensive (loss) income attributable to A&F	$ (376)	$ 37,448	$ (43,408)	$ (44,815)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 29, 2016	Jan. 30, 2016
Current assets:
Cash and equivalents	$ 469,720	$ 588,578
Receivables	71,235	56,868
Inventories, net	516,146	436,701
Other current assets	93,170	96,833
Total current assets	1,150,271	1,178,980
Property and equipment, net	827,996	894,178
Other assets	358,201	359,881
Total assets	2,336,468	2,433,039
Current liabilities:
Accounts payable	228,880	184,175
Accrued expenses	266,761	321,237
Short-term portion of deferred lease credits	20,623	23,303
Income taxes payable	7,654	5,988
Short-term portion of borrowings, net	2,204	0
Total current liabilities	526,122	534,703
Long-term liabilities:
Long-term portion of deferred lease credits	77,800	89,256
Long-term portion of borrowings, net	285,029	286,235
Leasehold financing obligations	48,810	47,440
Other liabilities	179,085	179,683
Total long-term liabilities	590,724	602,614
Stockholders’ equity
Class A Common Stock - $0.01 par value: 150,000 shares authorized and 103,300 shares issued at each of October 29, 2016 and January 30, 2016	1,033	1,033
Paid-in capital	394,135	407,029
Retained earnings	2,440,069	2,530,196
Accumulated other comprehensive loss, net of tax	(113,192)	(114,619)
Treasury stock, at average cost: 35,617 and 35,952 shares at October 29, 2016 and January 30, 2016, respectively	(1,510,378)	(1,532,576)
Total Abercrombie & Fitch Co. stockholders’ equity	1,211,667	1,291,063
Noncontrolling interests	7,955	4,659
Total stockholders’ equity	1,219,622	1,295,722
Total liabilities and stockholders’ equity	$ 2,336,468	$ 2,433,039

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 29, 2016	Jan. 30, 2016
Stockholders’ equity
Treasury Stock, at Average Cost (in shares)	35,617,000	35,952,000
Class A Common Stock
Stockholders’ equity
Class A Common Stock, par value	$ 0.01	$ 0.01
Class A Common Stock, shares authorized	150,000,000	150,000,000
Class A Common Stock, shares issued	103,300,000	103,300,000

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015
Operating activities
Net loss	$ (42,387)	$ (20,349)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	146,666	160,364
Asset impairment	6,356	18,209
Loss on disposal	1,914	6,312
Amortization of deferred lease credits	(18,601)	(21,482)
Benefit from deferred income taxes	(26,817)	(36,747)
Share-based compensation	16,691	21,681
Changes in assets and liabilities
Inventories, net	(91,375)	(141,725)
Accounts payable and accrued expenses	9,533	148,832
Lessor construction allowances	4,976	4,743
Income taxes	(6,463)	(34,249)
Return of long-term lease deposit	22,801	0
Other assets	(3,692)	(9,268)
Other liabilities	1,776	(29,781)
Net cash provided by operating activities	21,378	66,540
Investing activities
Purchases of property and equipment	(96,814)	(105,216)
Proceeds from sale of property and equipment	4,098	11,109
Other investing activities	0	(9,544)
Net cash used for investing activities	(92,716)	(84,563)
Financing activities
Purchase of treasury stock	0	50,033
Repayments of borrowings	0	(2,250)
Dividends paid	(40,526)	(41,704)
Other financing activities	(4,126)	147
Net cash used for financing activities	(44,652)	(93,840)
Effect of exchange rates on cash	(2,868)	(3,234)
Net decrease in cash and equivalents	(118,858)	(115,097)
Cash and equivalents, beginning of period	588,578	520,708
Cash and equivalents, end of period	469,720	405,611
Significant non-cash investing activities
Change in accrual for construction in progress	(12,453)	22,882
Supplemental information
Cash paid for interest	11,538	12,220
Cash paid for income taxes, net of refunds	$ 20,516	$ 45,100

Basis of Presentation

Basis of Presentation	9 Months Ended
	Oct. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Nature of Business Abercrombie & Fitch Co. (“A&F”), through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a specialty retailer of branded apparel and accessories. The Company operates stores in North America, Europe, Asia and the Middle East and direct-to-consumer operations in North America, Europe and Asia that serve its customers throughout the world. Principles of Consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its assets, liabilities, results of operations and cash flows. The Company has interests in a United Arab Emirates business venture and in a Kuwait business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the assets, liabilities, results of operations and cash flows of these VIEs. Fiscal Year The Company’s fiscal year ends on the Saturday closest to January 31. All references herein to “Fiscal 2016 ” and “Fiscal 2015 ” represent the fifty-two week fiscal years ending on January 28, 2017 and ended on January 30, 2016 , respectively. Interim Financial Statements The Condensed Consolidated Financial Statements as of October 29, 2016 , and for the thirteen and thirty-nine week periods ended October 29, 2016 and October 31, 2015 , are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, these Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2015 filed with the SEC on March 28, 2016. The January 30, 2016 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position and results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2016 . Recent Accounting Pronouncements The following table provides a brief description of recent accounting pronouncements that could affect the Company’s financial statements: Accounting Standards Update (ASU) Description Date of Adoption Effect on the Financial Statements or Other Significant Matters Standards not yet adopted ASU 2015-11, Simplifying the Measurement of Inventory This update amends ASC 330, Inventory . The new guidance applies to inventory measured using first-in, first-out (FIFO) or average cost. Under this amendment, inventory should be measured at the lower of cost and net realizable value, which is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. January 29, 2017* The adoption of this amendment is not expected to have a material impact on the Company’s consolidated financial statements. ASU 2016-09, Compensation—Stock Compensation This update amends ASC 718, Compensation . Under the new guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments will be recognized as income tax benefits or expenses in the statement of operations, whereas under the current guidance such benefits and deficiencies are recorded in additional paid-in-capital. The cash flow effects of the tax benefit will be reported in cash flows from operating activities, whereas they are currently reported in cash flows from financing activities. This guidance also allows for entities to make a policy election to estimate forfeitures or account for them when they occur. January 29, 2017* The Company is currently evaluating the method of adoption and the impact that this standard will have on its consolidated financial statements. ASU 2014-09, Revenue from Contracts with Customers This update supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . The new guidance requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. February 4, 2018 The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements. ASU 2016-02, Leases This update supersedes the leasing requirements in ASC 840, Leases . The new guidance requires an entity to recognize lease assets and lease liabilities on the balance sheet and disclose key leasing information that depicts the lease rights and obligations of an entity. February 3, 2019* The Company is currently evaluating the impact that this standard will have on its consolidated financial statements, but expects that it will result in a significant increase in the Company’s long-term assets and long-term liabilities on the Company's consolidated balance sheets. * Early adoption is permitted.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 29, 2016
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER SHARE	NET INCOME (LOSS) PER SHARE Net income (loss) per basic and diluted share is computed based on the weighted-average number of outstanding shares of common stock. The following table presents weighted-average shares outstanding and anti-dilutive shares: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Shares of common stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (35,325 ) (34,434 ) (35,452 ) (33,937 ) Weighted-average — basic shares 67,975 68,866 67,848 69,363 Dilutive effect of share-based compensation awards 302 399 — — Weighted-average — diluted shares 68,277 69,265 67,848 69,363 Anti-dilutive shares (1) 6,126 10,205 6,209 12,154 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive.

Fair Value

Fair Value	9 Months Ended
	Oct. 29, 2016
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows: • Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date. • Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly. • Level 3—inputs to the valuation methodology are unobservable. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution within it of the Company’s assets and liabilities, which are measured at fair value on a recurring basis, were as follows: Assets and Liabilities at Fair Value as of October 29, 2016 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 98,896 $ — $ 98,896 Money market funds 21 — — 21 Derivative financial instruments — 6,460 — 6,460 Total assets $ 21 $ 105,356 $ — $ 105,377 Liabilities: Derivative financial instruments $ — $ 262 $ — $ 262 Assets at Fair Value as of January 30, 2016 (in thousands) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 311,349 $ — $ — $ 311,349 Derivative financial instruments — 4,166 — 4,166 Total assets $ 311,349 $ 4,166 $ — $ 315,515 The Level 2 assets and liabilities consist of trust-owned life insurance policies and derivative financial instruments, primarily foreign currency exchange forward contracts. The fair value of foreign currency exchange forward contracts is determined by using quoted market prices of the same or similar instruments, adjusted for counterparty risk. Fair value of borrowings: The Company’s borrowings under the Company’s credit facilities are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. For disclosure purposes, the Company estimated the fair value of borrowings outstanding based on market rates for similar types of debt, which are considered to be Level 2 inputs. The carrying amount and fair value of the Company’s term loan facility were as follows: (in thousands) October 29, 2016 January 30, 2016 Gross borrowings outstanding, carrying amount $ 293,250 $ 293,250 Gross borrowings outstanding, fair value $ 293,250 $ 284,453 No borrowings were outstanding under the Company’s senior secured revolving credit facility as of October 29, 2016 or January 30, 2016 .

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 29, 2016
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	PROPERTY AND EQUIPMENT, NET Property and equipment, net consisted of: (in thousands) October 29, 2016 January 30, 2016 Property and equipment, at cost $ 2,805,449 $ 2,792,437 Less: Accumulated depreciation and amortization (1,977,453 ) (1,898,259 ) Property and equipment, net $ 827,996 $ 894,178 Long-lived assets, primarily comprised of leasehold improvements, furniture, fixtures and equipment, are tested for recoverability whenever events or changes in circumstances indicate that the carrying amount of the long-lived assets might not be recoverable. These include, but are not limited to, material declines in operational performance, a history of losses, an expectation of future losses, other than temporary adverse market conditions and store closure or relocation decisions. On at least a quarterly basis, the Company reviews for indicators of impairment at the individual store level, the lowest level for which cash flows are identifiable. Stores that display an indicator of impairment are subjected to an impairment assessment. The Company’s impairment assessment requires management to make assumptions and judgments related, but not limited, to management’s expectations for future operations and projected cash flows. The key assumptions used in the Company’s undiscounted future cash flow models include sales, gross margin and, to a lesser extent, operating expenses. An impairment loss would be recognized when these undiscounted future cash flows are less than the carrying amount of the asset group. In the circumstance of impairment, the loss would be measured as the excess of the carrying amount of the asset group over its fair value. The key assumptions used in estimating the fair value of impaired assets may include projected cash flows and discount rate. There were no non-cash asset impairment charges for the thirteen weeks ended October 29, 2016 . The Company incurred non-cash asset impairment charges of $6.4 million for the thirty-nine weeks ended October 29, 2016 . The Company incurred non-cash asset impairment charges of $12.1 million for the thirteen weeks ended October 31, 2015 and $18.2 million for the thirty-nine weeks ended October 31, 2015. The Company had $37.0 million and $37.3 million of construction project assets in property and equipment, net at October 29, 2016 and January 30, 2016 , respectively, related to the construction of buildings in certain lease arrangements where the Company is deemed to be the owner of the construction project.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 29, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s quarterly tax provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in law, regulations, and administrative practices, relative changes of expenses or losses for which tax benefits are not recognized and the impact of discrete items. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax income (loss) .

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Oct. 29, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
SHARE-BASED COMPENSATION	SHARE-BASED COMPENSATION The Company recognized share-based compensation expense of $5.7 million and $16.7 million for the thirteen and thirty-nine weeks ended October 29, 2016 , respectively, and $7.6 million and $21.7 million for the thirteen and thirty-nine weeks ended October 31, 2015 , respectively. The Company also recognized tax benefits related to share-based compensation of $2.2 million and $6.3 million for the thirteen and thirty-nine weeks ended October 29, 2016 , respectively, and $2.6 million and $7.4 million for the thirteen and thirty-nine weeks ended October 31, 2015 , respectively. Stock Options The following table summarizes stock option activity for the thirty-nine weeks ended October 29, 2016 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 30, 2016 271,000 $ 63.05 Granted — — Exercised (2,000 ) 22.87 Forfeited or expired (79,200 ) 31.53 Outstanding at October 29, 2016 189,800 $ 76.62 $ — 0.9 Stock options exercisable at October 29, 2016 189,800 $ 76.62 $ — 0.9 Stock Appreciation Rights The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 29, 2016 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 30, 2016 5,301,115 $ 45.02 Granted — — Exercised (10,483 ) 22.45 Forfeited or expired (1,194,207 ) 37.27 Outstanding at October 29, 2016 4,096,425 $ 47.43 $ — 3.0 Stock appreciation rights exercisable at October 29, 2016 3,524,010 $ 50.69 $ — 2.1 Stock appreciation rights expected to become exercisable in the future as of October 29, 2016 502,927 $ 27.60 $ — 8.1 As of October 29, 2016 , there was $3.7 million of total unrecognized compensation cost, net of estimated forfeitures, related to stock appreciation rights. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 13 months . The grant date fair value of stock appreciation rights that vested during the thirty-nine weeks ended October 29, 2016 and October 31, 2015 was $4.1 million and $4.5 million , respectively. Restricted Stock Units The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 29, 2016 : Service-based Restricted Stock Units Performance-based Restricted Stock Units Market-based Restricted Stock Units Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Unvested at January 30, 2016 1,671,597 $ 28.13 185,500 $ 23.42 117,711 $ 25.00 Granted 1,119,848 25.28 129,725 25.70 129,734 31.01 Adjustments for performance achievement — — — — — — Vested (603,789 ) 30.37 (32,625 ) 36.12 — — Forfeited (236,871 ) 26.75 (78,677 ) 24.22 (62,553 ) 31.91 Unvested at October 29, 2016 1,950,785 $ 25.97 203,923 $ 22.53 184,892 $ 26.89 Fair value of both service-based and performance-based restricted stock units is calculated using the market price of the underlying common stock on the date of grant reduced for anticipated dividend payments on unvested shares. In determining fair value, the Company does not take into account performance-based vesting requirements. Performance-based vesting requirements are taken into account in determining the number of awards expected to vest. For market-based restricted stock units, fair value is calculated using a Monte Carlo simulation with the number of shares that ultimately vest dependent on the Company’s total stockholder return measured against the total stockholder return of a select group of peer companies over a three-year period. For an award with performance-based or market-based vesting requirements, the number of shares that ultimately vest can vary from 0% to 200% of target depending on the level of achievement of performance criteria. Unvested shares related to restricted stock units with performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Service-based restricted stock units are expensed on a straight-line basis over the total requisite service period, net of forfeitures. Performance-based restricted stock units subject to graded vesting are expensed on an accelerated attribution basis, net of forfeitures. Market-based restricted stock units without graded vesting features are expensed on a straight-line basis over the requisite service period, net of forfeitures. As of October 29, 2016 , there was $30.7 million , $1.3 million and $3.1 million of total unrecognized compensation cost, net of estimated forfeitures, related to service-based, performance-based and market-based restricted stock units, respectively. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 16 months , 15 months and 14 months for service-based, performance-based and market-based restricted stock units, respectively. Additional information pertaining to restricted stock units for the thirty-nine weeks ended October 29, 2016 and October 31, 2015 follows: (in thousands) October 29, 2016 October 31, 2015 Service-based restricted stock units: Total grant date fair value of awards granted $ 28,310 $ 21,725 Total grant date fair value of awards vested 18,337 17,956 Performance-based restricted stock units: Total grant date fair value of awards granted $ 3,334 $ 2,278 Total grant date fair value of awards vested 1,178 1,861 Market-based restricted stock units: Total grant date fair value of awards granted $ 4,023 $ 2,158 Total grant date fair value of awards vested — — The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 29, 2016 and October 31, 2015 were as follows: October 29, 2016 October 31, 2015 Grant date market price $ 28.06 $ 22.46 Fair value $ 31.01 $ 19.04 Assumptions: Price volatility 45 % 45 % Expected term (years) 2.7 2.8 Risk-free interest rate 1.0 % 0.9 % Dividend yield 3.0 % 3.5 % Average volatility of peer companies 34.5 % 34.0 % Average correlation coefficient of peer companies 0.3415 0.3288

Derivative Instruments

Derivative Instruments	9 Months Ended
	Oct. 29, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS The Company is exposed to risks associated with changes in foreign currency exchange rates and uses derivative instruments, primarily forward contracts, to manage the financial impacts of these exposures. The Company does not use forward contracts to engage in currency speculation and does not enter into derivative financial instruments for trading purposes. The Company uses derivative instruments, primarily forward contracts designated as cash flow hedges, to hedge the foreign currency exposure associated with forecasted foreign-currency-denominated intercompany inventory sales to foreign subsidiaries and the related settlement of the foreign-currency-denominated intercompany receivables. Fluctuations in exchange rates will either increase or decrease the Company’s intercompany equivalent cash flows and affect the Company’s U.S. Dollar earnings. Gains or losses on the foreign currency exchange forward contracts that are used to hedge these exposures are expected to partially offset this variability. Foreign currency exchange forward contracts represent agreements to exchange the currency of one country for the currency of another country at an agreed upon settlement date. These forward contracts typically have a maximum term of twelve months . The sale of the inventory to the Company’s customers will result in the reclassification of related derivative gains and losses that are reported in accumulated other comprehensive loss (“AOCL”). Substantially all of the unrealized gains or losses related to designated cash flow hedges as of October 29, 2016 will be recognized in cost of sales, exclusive of depreciation and amortization, over the next twelve months . The Company presents its derivative assets and derivative liabilities at their gross fair values on the Condensed Consolidated Balance Sheets. However, the Company's master netting and other similar arrangements allow net settlements under certain conditions. As of October 29, 2016 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 82,321 British pound $ 34,335 Canadian dollar $ 16,949 Japanese yen $ 9,615 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2016 . The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in exchange rates result in transaction gains/(losses) being recorded in earnings as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of October 29, 2016 , the Company had no outstanding foreign currency exchange forward contracts that were entered into to hedge foreign-currency-denominated net monetary assets/liabilities. The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets as of October 29, 2016 and January 30, 2016 were as follows: (in thousands) Location October 29, January 30, Location October 29, January 30, Derivatives designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ 6,460 $ 4,097 Accrued expenses $ 262 $ — Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ — $ 69 Accrued expenses $ — $ — Total Other current assets $ 6,460 $ 4,166 Accrued expenses $ 262 $ — Refer to Note 3, “ FAIR VALUE, ” for further discussion of the determination of the fair value of derivative instruments. The location and amounts of derivative gains and losses for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 (in thousands) Location Gain/(Loss) Gain/(Loss) Gain/(Loss) Gain/(Loss) Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other operating income, net $ 152 $ 10 $ 295 $ 434 Effective Portion Ineffective Portion and Amount Excluded from Effectiveness Testing Amount of Gain (Loss) Recognized in OCI on Derivative Contracts (1) Location of Gain (Loss) Reclassified from AOCL into Earnings Amount of Gain (Loss) Reclassified from AOCL into Earnings (2) Location of Gain Recognized in Earnings on Derivative Contracts Amount of Gain Recognized in Earnings on Derivative Contracts (3) Thirteen Weeks Ended (in thousands) October 29, October 31, October 29, October 31, October 29, October 31, Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ 4,986 $ 933 Cost of sales, exclusive of depreciation and amortization $ 450 $ 2,886 Other operating income, net $ 695 $ 58 Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ 3,026 $ 3,318 Cost of sales, exclusive of depreciation and amortization $ 2,551 $ 13,761 Other operating income, net $ 1,308 $ 297 (1) The amount represents the change in fair value of derivative contracts due to changes in spot rates. (2) The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers. (3) The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Oct. 29, 2016
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE LOSS	ACCUMULATED OTHER COMPREHENSIVE LOSS The activity in accumulated other comprehensive loss for the thirteen and thirty-nine weeks ended October 29, 2016 was as follows: Thirteen Weeks Ended October 29, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 30, 2016 $ (106,132 ) $ 1,197 $ (104,935 ) Other comprehensive (loss) income before reclassifications (12,194 ) 4,986 (7,208 ) Reclassified from accumulated other comprehensive loss (1) — (450 ) (450 ) Tax effect — (599 ) (599 ) Other comprehensive (loss) income (12,194 ) 3,937 (8,257 ) Ending balance at October 29, 2016 $ (118,326 ) $ 5,134 $ (113,192 ) Thirty-nine Weeks Ended October 29, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2016 $ (119,196 ) $ 4,577 $ (114,619 ) Other comprehensive income before reclassifications 870 3,026 3,896 Reclassified from accumulated other comprehensive loss (1) — (2,551 ) (2,551 ) Tax effect — 82 82 Other comprehensive income 870 557 1,427 Ending balance at October 29, 2016 $ (118,326 ) $ 5,134 $ (113,192 ) (1) For the thirteen and thirty-nine weeks ended October 29, 2016 , a loss was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). The activity in accumulated other comprehensive loss for the thirteen and thirty-nine weeks ended October 31, 2015 was as follows: Thirteen Weeks Ended October 31, 2015 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 1, 2015 $ (106,551 ) $ 4,764 $ (101,787 ) Other comprehensive loss before reclassifications (1,384 ) (123 ) (1,507 ) Reclassified from accumulated other comprehensive loss (2) — (2,886 ) (2,886 ) Tax effect (107 ) 57 (50 ) Other comprehensive loss (1,491 ) (2,952 ) (4,443 ) Ending balance at October 31, 2015 $ (108,042 ) $ 1,812 $ (106,230 ) Thirty-nine Weeks Ended October 31, 2015 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 31, 2015 $ (96,680 ) $ 13,100 $ (83,580 ) Other comprehensive (loss) income before reclassifications (11,255 ) 2,263 (8,992 ) Reclassified from accumulated other comprehensive loss (2) — (13,761 ) (13,761 ) Tax effect (107 ) 210 103 Other comprehensive loss (11,362 ) (11,288 ) (22,650 ) Ending balance at October 31, 2015 $ (108,042 ) $ 1,812 $ (106,230 ) (2) For the thirteen and thirty-nine weeks ended October 31, 2015 , a loss was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).

Segment Reporting

Segment Reporting	9 Months Ended
	Oct. 29, 2016
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING The Company has two operating segments: Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands; and Hollister. These operating segments have similar economic characteristics, classes of consumers, products, and production and distribution methods, and have been aggregated into one reportable segment. The following table provides the Company’s net sales by operating segment for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 . Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Abercrombie $ 358,255 $ 411,259 $ 1,044,667 $ 1,131,626 Hollister 463,479 467,313 1,245,710 1,274,124 Total $ 821,734 $ 878,572 $ 2,290,377 $ 2,405,750 The following table provides the Company’s net sales by geographic area for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 . Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 United States $ 531,449 $ 572,736 $ 1,435,633 $ 1,536,151 Europe 187,184 206,538 541,711 572,772 Other 103,101 99,298 313,033 296,827 Total $ 821,734 $ 878,572 $ 2,290,377 $ 2,405,750

Contingencies

Contingencies	9 Months Ended
	Oct. 29, 2016
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES The Company is a defendant in lawsuits and other adversary proceedings arising in the ordinary course of business. Legal costs incurred in connection with the resolution of claims and lawsuits are generally expensed as incurred, and the Company establishes reserves for the outcome of litigation where losses are deemed probable and reasonably estimable. The Company’s assessment of the current exposure could change in the event of the discovery of additional facts. As of October 29, 2016, the Company had accrued charges of approximately $4 million for certain legal contingencies. In addition, there are certain claims and legal proceedings pending against the Company for which accruals have not been established. Actual liabilities may exceed the amounts reserved, and there can be no assurance that final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 29, 2016
Subsequent Event [Line Items]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On November 11, 2016, the Company exercised a lease kick-out option for its A&F flagship store in Hong Kong. The Company expects the closure of this store to be substantially complete by the end of the second quarter of Fiscal 2017. As a result of this decision, the Company expects to incur a lease termination charge of approximately $16 million during the fourth quarter of Fiscal 2016. In addition, the Company estimates the net cash outflow associated with this lease termination to be approximately $16 million , consisting of two payments of approximately $8 million each, with the first payment expected to be paid in the fourth quarter of Fiscal 2016 and the second payment expected to be paid in the second quarter of Fiscal 2017.

Basis of Presentation Nature of

Basis of Presentation Nature of Business (Policies)	9 Months Ended
	Oct. 29, 2016
Basis of Presentation [Abstract]
Nature of Business [Text Block]	Nature of Business Abercrombie & Fitch Co. (“A&F”), through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a specialty retailer of branded apparel and accessories. The Company operates stores in North America, Europe, Asia and the Middle East and direct-to-consumer operations in North America, Europe and Asia that serve its customers throughout the world.

Basis of Presentation Principle

Basis of Presentation Principles of Consolidation (Policies)	9 Months Ended
	Oct. 29, 2016
Basis of Presentation [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its assets, liabilities, results of operations and cash flows. The Company has interests in a United Arab Emirates business venture and in a Kuwait business venture with Majid al Futtaim Fashion L.L.C. (“MAF”), each of which meets the definition of a variable interest entity (“VIE”). The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the assets, liabilities, results of operations and cash flows of these VIEs.

Basis of Presentation Fiscal Ye

Basis of Presentation Fiscal Years (Policies)	9 Months Ended
	Oct. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period, Policy [Policy Text Block]	Fiscal Year The Company’s fiscal year ends on the Saturday closest to January 31. All references herein to “Fiscal 2016 ” and “Fiscal 2015 ” represent the fifty-two week fiscal years ending on January 28, 2017 and ended on January 30, 2016 , respectively.

Contingencies (Policies)

Contingencies (Policies)	9 Months Ended
	Oct. 29, 2016
Loss Contingencies [Line Items]
Contingent Liability Reserve Estimate, Policy [Policy Text Block]	The Company is a defendant in lawsuits and other adversary proceedings arising in the ordinary course of business. Legal costs incurred in connection with the resolution of claims and lawsuits are generally expensed as incurred, and the Company establishes reserves for the outcome of litigation where losses are deemed probable and reasonably estimable. The Company’s assessment of the current exposure could change in the event of the discovery of additional facts.

Basis of Presentation Recent Ac

Basis of Presentation Recent Accounting Pronouncements (Tables)	9 Months Ended
	Oct. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	The following table provides a brief description of recent accounting pronouncements that could affect the Company’s financial statements: Accounting Standards Update (ASU) Description Date of Adoption Effect on the Financial Statements or Other Significant Matters Standards not yet adopted ASU 2015-11, Simplifying the Measurement of Inventory This update amends ASC 330, Inventory . The new guidance applies to inventory measured using first-in, first-out (FIFO) or average cost. Under this amendment, inventory should be measured at the lower of cost and net realizable value, which is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. January 29, 2017* The adoption of this amendment is not expected to have a material impact on the Company’s consolidated financial statements. ASU 2016-09, Compensation—Stock Compensation This update amends ASC 718, Compensation . Under the new guidance, tax benefits and certain tax deficiencies arising from the vesting of share-based payments will be recognized as income tax benefits or expenses in the statement of operations, whereas under the current guidance such benefits and deficiencies are recorded in additional paid-in-capital. The cash flow effects of the tax benefit will be reported in cash flows from operating activities, whereas they are currently reported in cash flows from financing activities. This guidance also allows for entities to make a policy election to estimate forfeitures or account for them when they occur. January 29, 2017* The Company is currently evaluating the method of adoption and the impact that this standard will have on its consolidated financial statements. ASU 2014-09, Revenue from Contracts with Customers This update supersedes the revenue recognition requirements in ASC 605, Revenue Recognition . The new guidance requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. February 4, 2018 The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements. ASU 2016-02, Leases This update supersedes the leasing requirements in ASC 840, Leases . The new guidance requires an entity to recognize lease assets and lease liabilities on the balance sheet and disclose key leasing information that depicts the lease rights and obligations of an entity. February 3, 2019* The Company is currently evaluating the impact that this standard will have on its consolidated financial statements, but expects that it will result in a significant increase in the Company’s long-term assets and long-term liabilities on the Company's consolidated balance sheets. * Early adoption is permitted.

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Table)	9 Months Ended
	Oct. 29, 2016
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	The following table presents weighted-average shares outstanding and anti-dilutive shares: Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Shares of common stock issued 103,300 103,300 103,300 103,300 Weighted-average treasury shares (35,325 ) (34,434 ) (35,452 ) (33,937 ) Weighted-average — basic shares 67,975 68,866 67,848 69,363 Dilutive effect of share-based compensation awards 302 399 — — Weighted-average — diluted shares 68,277 69,265 67,848 69,363 Anti-dilutive shares (1) 6,126 10,205 6,209 12,154 (1) Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Oct. 29, 2016
Fair Value Disclosures [Abstract]
Company's Assets and Liabilities Measured at Fair Value	The three levels of the hierarchy and the distribution within it of the Company’s assets and liabilities, which are measured at fair value on a recurring basis, were as follows: Assets and Liabilities at Fair Value as of October 29, 2016 (in thousands) Level 1 Level 2 Level 3 Total Assets: Trust-owned life insurance policies (at cash surrender value) $ — $ 98,896 $ — $ 98,896 Money market funds 21 — — 21 Derivative financial instruments — 6,460 — 6,460 Total assets $ 21 $ 105,356 $ — $ 105,377 Liabilities: Derivative financial instruments $ — $ 262 $ — $ 262 Assets at Fair Value as of January 30, 2016 (in thousands) Level 1 Level 2 Level 3 Total Assets: Money market funds $ 311,349 $ — $ — $ 311,349 Derivative financial instruments — 4,166 — 4,166 Total assets $ 311,349 $ 4,166 $ — $ 315,515
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]	The carrying amount and fair value of the Company’s term loan facility were as follows: (in thousands) October 29, 2016 January 30, 2016 Gross borrowings outstanding, carrying amount $ 293,250 $ 293,250 Gross borrowings outstanding, fair value $ 293,250 $ 284,453

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 29, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net consisted of: (in thousands) October 29, 2016 January 30, 2016 Property and equipment, at cost $ 2,805,449 $ 2,792,437 Less: Accumulated depreciation and amortization (1,977,453 ) (1,898,259 ) Property and equipment, net $ 827,996 $ 894,178

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Oct. 29, 2016
Schedule of Stock Option Activity	The following table summarizes stock option activity for the thirty-nine weeks ended October 29, 2016 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 30, 2016 271,000 $ 63.05 Granted — — Exercised (2,000 ) 22.87 Forfeited or expired (79,200 ) 31.53 Outstanding at October 29, 2016 189,800 $ 76.62 $ — 0.9 Stock options exercisable at October 29, 2016 189,800 $ 76.62 $ — 0.9
Schedule of Stock Appreciation Rights Activity	The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended October 29, 2016 : Number of Underlying Shares Weighted-Average Exercise Price Aggregate Intrinsic Value Weighted-Average Remaining Contractual Life Outstanding at January 30, 2016 5,301,115 $ 45.02 Granted — — Exercised (10,483 ) 22.45 Forfeited or expired (1,194,207 ) 37.27 Outstanding at October 29, 2016 4,096,425 $ 47.43 $ — 3.0 Stock appreciation rights exercisable at October 29, 2016 3,524,010 $ 50.69 $ — 2.1 Stock appreciation rights expected to become exercisable in the future as of October 29, 2016 502,927 $ 27.60 $ — 8.1
Schedule of Restricted Stock Unit Activity	The following table summarizes activity for restricted stock units for the thirty-nine weeks ended October 29, 2016 : Service-based Restricted Stock Units Performance-based Restricted Stock Units Market-based Restricted Stock Units Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Number of Underlying Shares Weighted- Average Grant Date Fair Value Unvested at January 30, 2016 1,671,597 $ 28.13 185,500 $ 23.42 117,711 $ 25.00 Granted 1,119,848 25.28 129,725 25.70 129,734 31.01 Adjustments for performance achievement — — — — — — Vested (603,789 ) 30.37 (32,625 ) 36.12 — — Forfeited (236,871 ) 26.75 (78,677 ) 24.22 (62,553 ) 31.91 Unvested at October 29, 2016 1,950,785 $ 25.97 203,923 $ 22.53 184,892 $ 26.89
Market-based restricted stock units [Member]
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions	The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended October 29, 2016 and October 31, 2015 were as follows: October 29, 2016 October 31, 2015 Grant date market price $ 28.06 $ 22.46 Fair value $ 31.01 $ 19.04 Assumptions: Price volatility 45 % 45 % Expected term (years) 2.7 2.8 Risk-free interest rate 1.0 % 0.9 % Dividend yield 3.0 % 3.5 % Average volatility of peer companies 34.5 % 34.0 % Average correlation coefficient of peer companies 0.3415 0.3288

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Oct. 29, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Foreign Exchange Forward Contracts	As of October 29, 2016 , the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory sales, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both: (in thousands) Notional Amount (1) Euro $ 82,321 British pound $ 34,335 Canadian dollar $ 16,949 Japanese yen $ 9,615 (1) Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2016 . The Company also uses foreign currency exchange forward contracts to hedge certain foreign-currency-denominated net monetary assets/liabilities. Examples of monetary assets/liabilities include cash balances, receivables and payables. Fluctuations in exchange rates result in transaction gains/(losses) being recorded in earnings as U.S. GAAP requires that monetary assets/liabilities be remeasured at the spot exchange rate at quarter-end or upon settlement. The Company has chosen not to apply hedge accounting to these instruments because there are no differences in the timing of gain or loss recognition on the hedging instruments and the hedged items. As of October 29, 2016 , the Company had no outstanding foreign currency exchange forward contracts that were entered into to hedge foreign-currency-denominated net monetary assets/liabilities.
Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets	The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets as of October 29, 2016 and January 30, 2016 were as follows: (in thousands) Location October 29, January 30, Location October 29, January 30, Derivatives designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ 6,460 $ 4,097 Accrued expenses $ 262 $ — Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other current assets $ — $ 69 Accrued expenses $ — $ — Total Other current assets $ 6,460 $ 4,166 Accrued expenses $ 262 $ —
Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss	The location and amounts of derivative gains and losses for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows: Thirteen Weeks Ended Thirty-nine Weeks Ended October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 (in thousands) Location Gain/(Loss) Gain/(Loss) Gain/(Loss) Gain/(Loss) Derivatives not designated as hedging instruments: Foreign currency exchange forward contracts Other operating income, net $ 152 $ 10 $ 295 $ 434 Effective Portion Ineffective Portion and Amount Excluded from Effectiveness Testing Amount of Gain (Loss) Recognized in OCI on Derivative Contracts (1) Location of Gain (Loss) Reclassified from AOCL into Earnings Amount of Gain (Loss) Reclassified from AOCL into Earnings (2) Location of Gain Recognized in Earnings on Derivative Contracts Amount of Gain Recognized in Earnings on Derivative Contracts (3) Thirteen Weeks Ended (in thousands) October 29, October 31, October 29, October 31, October 29, October 31, Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ 4,986 $ 933 Cost of sales, exclusive of depreciation and amortization $ 450 $ 2,886 Other operating income, net $ 695 $ 58 Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Derivatives in cash flow hedging relationships: Foreign currency exchange forward contracts $ 3,026 $ 3,318 Cost of sales, exclusive of depreciation and amortization $ 2,551 $ 13,761 Other operating income, net $ 1,308 $ 297 (1) The amount represents the change in fair value of derivative contracts due to changes in spot rates. (2) The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers. (3) The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensi27

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Oct. 29, 2016
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The activity in accumulated other comprehensive loss for the thirteen and thirty-nine weeks ended October 29, 2016 was as follows: Thirteen Weeks Ended October 29, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at July 30, 2016 $ (106,132 ) $ 1,197 $ (104,935 ) Other comprehensive (loss) income before reclassifications (12,194 ) 4,986 (7,208 ) Reclassified from accumulated other comprehensive loss (1) — (450 ) (450 ) Tax effect — (599 ) (599 ) Other comprehensive (loss) income (12,194 ) 3,937 (8,257 ) Ending balance at October 29, 2016 $ (118,326 ) $ 5,134 $ (113,192 ) Thirty-nine Weeks Ended October 29, 2016 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 30, 2016 $ (119,196 ) $ 4,577 $ (114,619 ) Other comprehensive income before reclassifications 870 3,026 3,896 Reclassified from accumulated other comprehensive loss (1) — (2,551 ) (2,551 ) Tax effect — 82 82 Other comprehensive income 870 557 1,427 Ending balance at October 29, 2016 $ (118,326 ) $ 5,134 $ (113,192 ) (1) For the thirteen and thirty-nine weeks ended October 29, 2016 , a loss was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). The activity in accumulated other comprehensive loss for the thirteen and thirty-nine weeks ended October 31, 2015 was as follows: Thirteen Weeks Ended October 31, 2015 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at August 1, 2015 $ (106,551 ) $ 4,764 $ (101,787 ) Other comprehensive loss before reclassifications (1,384 ) (123 ) (1,507 ) Reclassified from accumulated other comprehensive loss (2) — (2,886 ) (2,886 ) Tax effect (107 ) 57 (50 ) Other comprehensive loss (1,491 ) (2,952 ) (4,443 ) Ending balance at October 31, 2015 $ (108,042 ) $ 1,812 $ (106,230 ) Thirty-nine Weeks Ended October 31, 2015 (in thousands) Foreign Currency Translation Adjustment Unrealized Gain (Loss) on Derivative Financial Instruments Total Beginning balance at January 31, 2015 $ (96,680 ) $ 13,100 $ (83,580 ) Other comprehensive (loss) income before reclassifications (11,255 ) 2,263 (8,992 ) Reclassified from accumulated other comprehensive loss (2) — (13,761 ) (13,761 ) Tax effect (107 ) 210 103 Other comprehensive loss (11,362 ) (11,288 ) (22,650 ) Ending balance at October 31, 2015 $ (108,042 ) $ 1,812 $ (106,230 ) (2) For the thirteen and thirty-nine weeks ended October 31, 2015 , a loss was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Oct. 29, 2016
Segment Reporting [Abstract]
Revenue from External Customers by Operating Segment [Table Text Block]	The following table provides the Company’s net sales by operating segment for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 . Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 Abercrombie $ 358,255 $ 411,259 $ 1,044,667 $ 1,131,626 Hollister 463,479 467,313 1,245,710 1,274,124 Total $ 821,734 $ 878,572 $ 2,290,377 $ 2,405,750
Revenue from External Customers by Geographic Areas [Table Text Block]	The following table provides the Company’s net sales by geographic area for the thirteen and thirty-nine weeks ended October 29, 2016 and October 31, 2015 . Thirteen Weeks Ended Thirty-nine Weeks Ended (in thousands) October 29, 2016 October 31, 2015 October 29, 2016 October 31, 2015 United States $ 531,449 $ 572,736 $ 1,435,633 $ 1,536,151 Europe 187,184 206,538 541,711 572,772 Other 103,101 99,298 313,033 296,827 Total $ 821,734 $ 878,572 $ 2,290,377 $ 2,405,750

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - shares shares in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Weighted Average Shares Outstanding And Anti Dilutive Shares [Abstract]
Shares of common stock issued		103,300	103,300	103,300	103,300
Weighted-average treasury shares		(35,325)	(34,434)	(35,452)	(33,937)
Weighted-average — basic shares		67,975	68,866	67,848	69,363
Dilutive effect of share-based compensation awards		302	399	0	0
Weighted-average — diluted shares		68,277	69,265	67,848	69,363
Anti-dilutive shares (1)	[1]	6,126	10,205	6,209	12,154
[1]	Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net income (loss) per diluted share because the impact would have been anti-dilutive.

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities at Fair Value) (Details) - USD ($)	Oct. 29, 2016	Jan. 30, 2016
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	$ 98,896,000
Assets, Fair Value Disclosure [Abstract]
Money market funds	21,000	$ 311,349,000
Derivative financial instruments	6,460,000	4,166,000
Total assets	105,377,000	315,515,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	262,000
Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	0
Assets, Fair Value Disclosure [Abstract]
Money market funds	21,000	311,349,000
Derivative financial instruments	0	0
Total assets	21,000	311,349,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	0
Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	98,896,000
Assets, Fair Value Disclosure [Abstract]
Money market funds	0	0
Derivative financial instruments	6,460,000	4,166,000
Total assets	105,356,000	4,166,000
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	262,000	0
Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restricted Investments, Noncurrent	0
Assets, Fair Value Disclosure [Abstract]
Money market funds	0	0
Derivative financial instruments	0	0
Total assets	0	0
Liabilities, Fair Value Disclosure [Abstract]
Derivative financial instruments	0
Term Loan Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross borrowings outstanding, carrying amount	293,250,000	293,250,000
Gross borrowings outstanding, fair value	293,250,000	284,453,000
ABL Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Credit facility, amount outstanding	$ 0	$ 0

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015	Jan. 30, 2016
Property, Plant and Equipment [Line Items]
Property and equipment, at cost	$ 2,805,449		$ 2,805,449		$ 2,792,437
Less: Accumulated depreciation and amortization	(1,977,453)		(1,977,453)		(1,898,259)
Property and equipment, net	827,996		827,996		894,178
Asset Impairment Charges	0	$ 12,076	6,356	$ 18,209
Construction Project Assets [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 37,000		$ 37,000		$ 37,300

Share-Based Compensation (Detai

Share-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 5,700	$ 7,600	$ 16,691	$ 21,681
Tax benefit recognized related to share-based compensation expense	2,200	$ 2,600	$ 6,300	7,400
Target percentage of equity awards earned			100.00%
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	3,700		$ 3,700
Unrecognized compensation cost, weighted-average period of recognition			13 months
Total grant date fair value of awards vested			$ 4,100	4,500
Service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	30,700		$ 30,700
Unrecognized compensation cost, weighted-average period of recognition			16 months
Total grant date fair value of awards granted			$ 28,310	21,725
Total grant date fair value of awards vested			18,337	17,956
Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	1,300		$ 1,300
Unrecognized compensation cost, weighted-average period of recognition			15 months
Total grant date fair value of awards granted			$ 3,334	2,278
Total grant date fair value of awards vested			1,178	1,861
Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost, net of estimated forfeitures	$ 3,100		$ 3,100
Unrecognized compensation cost, weighted-average period of recognition			14 months
Total grant date fair value of awards granted			$ 4,023	2,158
Total grant date fair value of awards vested			$ 0	$ 0
Minimum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned			0.00%
Minimum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned			0.00%
Maximum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned			200.00%
Maximum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned			200.00%

Share-Based Compensation (Stock

Share-Based Compensation (Stock Option Activity) (Details)	9 Months Ended
	Oct. 29, 2016USD ($)$ / sharesshares
Stock Option Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2016 | shares	271,000
Number of Underlying Shares, Granted | shares	0
Number of Underlying Shares, Exercised | shares	(2,000)
Number of Underlying Shares, Forfeited or expired | shares	(79,200)
Number of Underlying Shares, Ending Balance at October 29, 2016 | shares	189,800
Number of Underlying Shares, Stock options exercisable at October 29, 2016 | shares	189,800
Stock Option Activity, Weighted Average Exercise Price
Weighted-Average Exercise Price, Beginning Balance at January 30, 2016 | $ / shares	$ 63.05
Weighted-Average Exercise Price, Granted | $ / shares	0
Weighted-Average Exercise Price, Exercised | $ / shares	22.87
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	31.53
Weighted-Average Exercise Price, Ending Balance at October 29, 2016 | $ / shares	76.62
Weighted-Average Exercise Price, Stock options exercisable | $ / shares	$ 76.62
Aggregate Intrinsic Value, Outstanding | $	$ 0
Aggregate Intrinsic Value, Stock options exercisable | $	$ 0
Weighted-Average Remaining Contractual Life (in years), Outstanding	10 months 24 days
Weighted-Average Remaining Contractual Life (in years), Stock options exercisable	10 months 24 days

Share-Based Compensation (Sto34

Share-Based Compensation (Stock Appreciation Rights Activity) (Details) - Stock Appreciation Rights	9 Months Ended
	Oct. 29, 2016USD ($)$ / sharesshares
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2016 | shares	5,301,115
Number of Underlying Shares, Granted | shares	0
Number of Underlying Shares, Exercised | shares	(10,483)
Number of Underlying Shares, Forfeited | shares	(1,194,207)
Number of Underlying Shares, Ending Balance at October 29, 2016 | shares	4,096,425
Number of Underlying shares, Stock appreciation rights exercisable | shares	3,524,010
Number of Underlying Shares, Stock appreciation rights expected to become exercisable | shares	502,927
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016 | $ / shares	$ 45.02
Weighted-Average Exercise Price, Granted | $ / shares	0
Weighted-Average Exercise Price, Exercised | $ / shares	22.45
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	37.27
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016 | $ / shares	47.43
Weighted-Average Exercise Price, Stock appreciation rights exercisable | $ / shares	50.69
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable | $ / shares	$ 27.60
Aggregate Intrinsic Value, Outstanding | $	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable | $	0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable | $	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	3 years
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 1 month 6 days
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	8 years 1 month 6 days

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - $ / shares	9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	100.00%
Service-based restricted stock units
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2016	1,671,597
Number of Underlying Shares, Granted	1,119,848
Number of Underlying Shares, Adjustments for performance achievement	0
Number of Underlying Shares, Vested	(603,789)
Number of Underlying Shares, Forfeited	(236,871)
Number of Underlying Shares, Ending Balance at October 29, 2016	1,950,785
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016	$ 28.13
Weighted-Average Grant Date Fair Value, Granted	25.28
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement	0
Weighted-Average Grant Date Fair Value, Vested	30.37
Weighted-Average Grant Date Fair Value, Forfeited	26.75
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016	$ 25.97
Performance-based restricted stock units [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2016	185,500
Number of Underlying Shares, Granted	129,725
Number of Underlying Shares, Adjustments for performance achievement	0
Number of Underlying Shares, Vested	(32,625)
Number of Underlying Shares, Forfeited	(78,677)
Number of Underlying Shares, Ending Balance at October 29, 2016	203,923
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016	$ 23.42
Weighted-Average Grant Date Fair Value, Granted	25.70
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement	0
Weighted-Average Grant Date Fair Value, Vested	36.12
Weighted-Average Grant Date Fair Value, Forfeited	24.22
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016	$ 22.53
Market-based restricted stock units [Member]
Restricted Stock Unit Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2016	117,711
Number of Underlying Shares, Granted	129,734
Number of Underlying Shares, Adjustments for performance achievement	0
Number of Underlying Shares, Vested	0
Number of Underlying Shares, Forfeited	(62,553)
Number of Underlying Shares, Ending Balance at October 29, 2016	184,892
Restricted Stock Unit Activity, Weighted-Average Grant Date Fair Value
Weighted-Average Grant Date Fair Value, Beginning Balance at January 30, 2016	$ 25
Weighted-Average Grant Date Fair Value, Granted	31.01	$ 19.04
Weighted-Average Grant Date Fair Value, Adjustments for performance achievement	0
Weighted-Average Grant Date Fair Value, Vested	0
Weighted-Average Grant Date Fair Value, Forfeited	31.91
Weighted-Average Grant Date Fair Value, Ending Balance at October 29, 2016	$ 26.89
Minimum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	0.00%
Minimum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	0.00%
Maximum | Performance-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	200.00%
Maximum | Market-based restricted stock units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage of equity awards earned	200.00%

Share-Based Compensation (Res36

Share-Based Compensation (Restricted Stock Units Assumptions) (Details) - Market-based restricted stock units [Member]	9 Months Ended
	Oct. 29, 2016$ / shares	Oct. 31, 2015$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date market price (in dollars per share)	$ 28.06	$ 22.46
Fair value (in dollars per share)	$ (31.01)	$ (19.04)
Price volatility	45.00%	45.00%
Expected term (years)	2 years 8 months 12 days	2 years 9 months 18 days
Risk-free interest rate	1.00%	0.90%
Dividend yield	3.00%	3.50%
Average volatility of peer companies	34.50%	34.00%
Average correlation coefficient of peer companies	0.3415	0.3288

Derivative Instruments (Outstan

Derivative Instruments (Outstanding Foreign Exchange Forward Contracts) (Details) - Cash Flow Hedging - Inter-company Inventory and Accounts Receivables - Forward Contracts $ in Thousands	Oct. 29, 2016USD ($)	[1]
Euro Member Countries, Euro
Derivative [Line Items]
Notional Amount	$ 82,321
United Kingdom, Pounds
Derivative [Line Items]
Notional Amount	34,335
Canada, Dollars
Derivative [Line Items]
Notional Amount	16,949
Japan, Yen
Derivative [Line Items]
Notional Amount	$ 9,615
[1]	Amounts reported are the U.S. Dollar notional amounts outstanding as of October 29, 2016.

Derivative Instruments (Derivat

Derivative Instruments (Derivative Fair Values on the Condensed Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Oct. 29, 2016	Jan. 30, 2016
Foreign currency exchange forward contracts | Other current assets | Designated As Hedging Instrument
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	$ 6,460	$ 4,097
Foreign currency exchange forward contracts | Other current assets | Not Designated as Hedging Instruments
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	0	69
Foreign currency exchange forward contracts | Accrued expenses | Designated As Hedging Instrument
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Accrued expenses	262	0
Foreign currency exchange forward contracts | Accrued expenses | Not Designated as Hedging Instruments
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Accrued expenses	0	0
Fair Value, Measurements, Recurring
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	6,460	4,166
Accrued expenses	262
Level 2 | Fair Value, Measurements, Recurring
The location and amounts of derivative fair values on the Condensed Consolidated Balance Sheets
Other current assets	6,460	4,166
Accrued expenses	$ 262	$ 0

Derivative Instruments (Deriv39

Derivative Instruments (Derivative Gains (Losses) on the Condensed Consolidated Statement of Operations) (Details) - Foreign currency exchange forward contracts - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in OCI on Derivative Contracts (Effective Portion)	[1]	$ 4,986	$ 933	$ 3,026	$ 3,318
Other operating income, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(Loss)		152	10	295	434
Other operating income, net | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in Earnings on Derivative Contracts (Ineffective Portion and Amount Excluded from Effectiveness Testing)	[2]	695	58	1,308	297
Cost of sales, exclusive of depreciation and amortization | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from AOCL into Earnings (Effective Portion)	[3]	$ 450	$ 2,886	$ 2,551	$ 13,761
[1]	The amount represents the change in fair value of derivative contracts due to changes in spot rates.
[2]	The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.
[3]	The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers.

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015	Jan. 30, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Length of time inventory sales hedged (in months)				12 months
Period in which remaining unrealized gains or losses on intercompany inventory sales are recognized				12 months
Foreign currency exchange forward contracts | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Recognized in OCI, Effective Portion, Net	[1]	$ 4,986	$ 933	$ 3,026	$ 3,318
Foreign currency exchange forward contracts | Cost of sales, exclusive of depreciation and amortization | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	[2]	450	2,886	2,551	13,761
Foreign currency exchange forward contracts | Other operating income, net | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in Earnings, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net	[3]	695	$ 58	1,308	$ 297
Fair Value, Measurements, Recurring
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		6,460		6,460		$ 4,166
Accrued expenses		262		262
Level 2 | Fair Value, Measurements, Recurring
Derivative Instruments, Gain (Loss) [Line Items]
Other current assets		6,460		6,460		4,166
Accrued expenses		$ 262		$ 262		$ 0
[1]	The amount represents the change in fair value of derivative contracts due to changes in spot rates.
[2]	The amount represents the reclassification from AOCL into earnings when the hedged item affects earnings, which is when merchandise is sold to the Company’s customers.
[3]	The amount represents the change in fair value of derivative contracts due to changes in the difference between the spot price and forward price that is excluded from the assessment of hedge effectiveness and, therefore, recognized in earnings.

Accumulated Other Comprehensi41

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015		Oct. 29, 2016	Oct. 31, 2015
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at July 30, 2016	$ (104,935)	$ (101,787)		$ (114,619)	$ (83,580)
Other comprehensive (loss) income before reclassifications	(7,208)	(1,507)		3,896	(8,992)
Reclassified from accumulated other comprehensive loss (1)	(450)	(2,886)	[1]	(2,551)	(13,761)
Tax effect	(599)	(50)		82	103
Other comprehensive (loss) income	(8,257)	(4,443)		1,427	(22,650)
Ending balance at October 29, 2016	(113,192)	(106,230)		(113,192)	(106,230)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at July 30, 2016	(106,132)	(106,551)		(119,196)	(96,680)
Other comprehensive (loss) income before reclassifications	(12,194)	(1,384)		870	(11,255)
Reclassified from accumulated other comprehensive loss (1)	0	0		0	0
Tax effect	0	(107)		0	(107)
Other comprehensive (loss) income	(12,194)	(1,491)		870	(11,362)
Ending balance at October 29, 2016	(118,326)	(108,042)		(118,326)	(108,042)
Unrealized Gain (Loss) on Derivative Financial Instruments
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance at July 30, 2016	1,197	4,764		4,577	13,100
Other comprehensive (loss) income before reclassifications	4,986	(123)		3,026	2,263
Reclassified from accumulated other comprehensive loss (1)	(450)	(2,886)		(2,551)	(13,761)
Tax effect	(599)	57		82	210
Other comprehensive (loss) income	3,937	(2,952)		557	(11,288)
Ending balance at October 29, 2016	$ 5,134	$ 1,812		$ 5,134	$ 1,812
[1]	For the thirteen and thirty-nine weeks ended October 31, 2015, a loss was reclassified from accumulated other comprehensive loss to cost of sales, exclusive of depreciation and amortization on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).

Segment Reporting (Segment Repo

Segment Reporting (Segment Reporting Information, by Segment) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016USD ($)	Oct. 31, 2015USD ($)	Oct. 29, 2016USD ($)	Oct. 31, 2015USD ($)
Segment Reporting Information [Line Items]
Number of Operating Segments	2
Number of reportable segments			1
Net Sales	$ 821,734	$ 878,572	$ 2,290,377	$ 2,405,750
Operating Loss	$ 19,645	$ 40,990	$ (46,071)	$ (47,245)

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Brand) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Schedule of Revenue by Brand [Line Items]
Net Sales	$ 821,734	$ 878,572	$ 2,290,377	$ 2,405,750
Abercrombie
Schedule of Revenue by Brand [Line Items]
Net Sales	358,255	411,259	1,044,667	1,131,626
Hollister
Schedule of Revenue by Brand [Line Items]
Net Sales	$ 463,479	$ 467,313	$ 1,245,710	$ 1,274,124

Segment Reporting (Sales by Geo

Segment Reporting (Sales by Geographic Area) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2016	Oct. 31, 2015	Oct. 29, 2016	Oct. 31, 2015
Net Sales	$ 821,734	$ 878,572	$ 2,290,377	$ 2,405,750
United States
Net Sales	531,449	572,736	1,435,633	1,536,151
Europe
Net Sales	187,184	206,538	541,711	572,772
Other
Net Sales	$ 103,101	$ 99,298	$ 313,033	$ 296,827

Contingencies (Details)

Contingencies (Details) $ in Millions	Oct. 29, 2016USD ($)
Loss Contingencies [Line Items]
Accrued legal contingencies	$ 4

Subsequent Events (Details)

Subsequent Events (Details)	3 Months Ended		9 Months Ended
	Jul. 29, 2017USD ($)	Jan. 28, 2017USD ($)	Jul. 29, 2017USD ($)
Subsequent Event [Line Items]
Gain (Loss) on Contract Termination		$ (16,000,000)
Number of Future Cash Payments			2
Future Cash Payments for Lease Termination	$ 8,000,000	$ 8,000,000	$ 16,000,000